| Studies with the following exclusion criteria |
Studies of exercise trials |
During treatment
(n= 25)a
n (%) |
After treatment
(n=48)b
n (%) |
| Comorbidities and medical conditions |
| Obesity (Body Mass Index>35, >40 or >50 kg/m2) |
2 (8)
[47,52] |
7 (15) [54,59,75,82,83,95,96] |
| Hypertension |
9 (36)
[37-39,42,43,46,49,51,53] |
11 (23) [12,54,60,62,72,73,75,80,82,100,101] |
| Known cardiac disease /uncontrolled/ severe/ cardiovascular disease |
14 (56)
[34,35,37-39,41,43-49,51] |
17 (35) [12,55,60,62,67-69,72,73,76-80,84,85,102] |
| Acute or chronic respiratory disease |
10 (40)
[34,37,41,43-49] |
3 (6) [67,84,102] |
| Psychological or psychiatric disorders/ diseases (current and/or history) |
11 (44)
[33,38-40,43-45,50, 52,53,97] |
10 (21) [12,57,60,61,70,78,86,92,99,102] |
| Neurological/ cognitive dysfunction |
4 (16)
[37,47-49] |
1 (2) [99] |
| Thyroid disease/uncontrolled |
0 (0) |
2 (4) [12,60] |
| Diabetes/type II diabetes |
1 (4)
[53] |
9 (19) [12,60,64,65,68,73,76-78] |
| Renal or hepatic disease |
1 (4)
[97] |
0 (0) |
| Major orthopaedic limitations/verified osteoporosis/severe arthritis/high risk of fracture |
3 (12)
[35,50,52,97] |
12 (25) [31,55,69,72,76,78-80,85,92,100,101] |
| Symptomatic bone metastases/ known metastatic disease |
4 (16)
[44,45,97,98] |
12 (25) [12,57,58,61,67,72,73,79-81,86,102] |
| Infection, immune or endocrine abnormality |
2 (8)
[50,98] |
7 (15) [12,60,67,80,96,101,102] |
| Disease- and treatment-related sequelae |
| Insomnia |
0 (0) |
1 (2) [61] |
| Severe nausea |
1 (4)
[52] |
1 (2) [92] |
| Anorexia |
0 (0) |
1 (2) [92] |
| Lymphoedema |
0 (0) |
2 (4) [62,101] |
| Uncontrolled pain/ bone pain/ > 2 on 0-10 pain scale |
2 (8)
[52,98] |
1 (2) [62]
|
| Abnormal levels in blood tests |
1 (4)
[46] |
0 (0) |
| Incomplete axillary surgery / trans-abdominal rectus abdominus muscle reconstructive surgery |
2 (8)
[38,39] |
0 (0) |
| General exclusion relating to physical function, overall health and/or ability to exercise, e.g., “any medical (physical and/or psychological) conditions that may limit participation” |
16 (64)
[33-36,40-48,52,53,97] |
28 (58)
[54,56,58,59,61,62,67,68,70,72-80,82-86,90,91,96,99,102] |
a[32-53,87,97,98]
b[12,31, 54-86,88-96,99-102] |
|
